AI, Value-Based Contracting, Digital Health Integration, and CMS Readiness Lead Consulting Priorities in Year Ahead, 18 ...

TAMPA, FL / ACCESS Newswire / June 13, 2025 / NeuroEM Therapeutics®, an award-winning clinical-stage biotechnology research company pioneering the use of radio frequencies to reverse Alzheimer's ...

Medical Component Specialists will be in Chicago for the 19th annual Orthopedic Manufacturing & Technology Exposition and ...

Health Plans and Payers Align Around VBRO Technology to Meet CMS Payment Reform Demands; Top-Rated Vendors Identified for ...

Unlocking New Wellness Markets with Precision Messaging and Storytelling Strategy for Growth CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / June 13, 2025 / Stories with Substance, a boutique marketing ...

GOTHENBURG, SWEDEN / ACCESS Newswire / June 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Yesterday, XVIVO received the prestigious Swedish American Chamber of Commerce USA (SACC-USA) ...

AUSTIN, TX / ACCESS Newswire / June 13, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and ...

SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its ...

The medical rehabilitation robotics market is steadily transforming the landscape of post-acute care and physical therapy. With a focus on assisting patients with mobility impairments, these robotic ...

The market has benefited from increased public awareness about health issues, urbanization and the spread of e-commerce sites on the internet. All of these factors have given consumers more choice in ...

The pelvic floor stimulators market will hit USD 166.1 Million come 2025. By 2035, it is set to grow more, reaching USD 393.4 Million. The rise will show a CAGR of 9% during the time frame. Demand for ...

The safety and efficacy profiles of these classes of therapeutics are continuously being enhanced by the development of novel drug formulations, or innovative drug delivery technologies, etc. In ...